Institutional & Family Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $9.89K | Buy |
257
+3
| +1% | +$115 | ﹤0.01% | 417 |
|
|
2024
Q1 | $10.9K | Buy |
254
+2
| +0.8% | +$86 | ﹤0.01% | 394 |
|
|
2023
Q4 | $9.34K | Buy |
252
+2
| +0.8% | +$74 | ﹤0.01% | 399 |
|
|
2023
Q3 | $9.06K | Buy |
250
+3
| +1% | +$109 | ﹤0.01% | 388 |
|
|
2023
Q2 | $8.81K | Buy |
247
+2
| +0.8% | +$71 | ﹤0.01% | 400 |
|
|
2023
Q1 | $8.72K | Buy |
245
+2
| +0.8% | +$71 | ﹤0.01% | 394 |
|
|
2022
Q4 | $8.54K | Buy |
243
+3
| +1% | +$105 | ﹤0.01% | 392 |
|
|
2022
Q3 | $7K | Sell |
240
-44
| -15% | -$1.28K | ﹤0.01% | 420 |
|
|
2022
Q2 | $15K | Buy |
284
+1
| +0.4% | +$53 | ﹤0.01% | 342 |
|
|
2022
Q1 | $15K | Hold |
283
| – | – | ﹤0.01% | 387 |
|
|
2021
Q4 | $16K | Buy |
283
+1
| +0.4% | +$57 | ﹤0.01% | 393 |
|
|
2021
Q3 | $13K | Hold |
282
| – | – | ﹤0.01% | 512 |
|
|
2021
Q2 | $14K | Buy |
282
+1
| +0.4% | +$50 | ﹤0.01% | 535 |
|
|
2021
Q1 | $13K | Hold |
281
| – | – | ﹤0.01% | 534 |
|
|
2020
Q4 | $13K | Buy |
281
+1
| +0.4% | +$46 | ﹤0.01% | 497 |
|
|
2020
Q3 | $13K | Hold |
280
| – | – | ﹤0.01% | 450 |
|
|
2020
Q2 | $14K | Buy |
280
+40
| +17% | +$2K | ﹤0.01% | 442 |
|
|
2020
Q1 | $11K | Hold |
240
| – | – | ﹤0.01% | 437 |
|
|
2019
Q4 | $14K | Hold |
240
| – | – | ﹤0.01% | 461 |
|
|
2019
Q3 | $13K | Hold |
240
| – | – | ﹤0.01% | 444 |
|
|
2019
Q2 | $12K | Hold |
240
| – | – | ﹤0.01% | 475 |
|
|
2019
Q1 | $13K | Hold |
240
| – | – | ﹤0.01% | 464 |
|
|
2018
Q4 | $11K | Hold |
240
| – | – | ﹤0.01% | 458 |
|
|
2018
Q3 | $12K | Hold |
240
| – | – | ﹤0.01% | 505 |
|
|
2018
Q2 | $12K | Hold |
240
| – | – | ﹤0.01% | 494 |
|
|
2018
Q1 | $12K | Buy |
+240
| New | +$12K | ﹤0.01% | 472 |
|